Skip to content
OpenCapital
Get started

Rani Therapeutics Holdings, Inc. RANI Q4 2024 Annual earnings

Reported March 31, 2025 · After market close

Revenue$1.0M
EPS-$0.27Miss by $0.03
EPS estimate-$0.24

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$925.0K
EPS estimate-$0.05

Versus estimates

Revenue

Q1 2026$1.7MBeat by $583.0KQ4 2025$1.5MMiss by $3.5MQ1 2025$172.0K
Q4 2024$1.0M

Diluted EPS

Q1 2026-$0.04Beat by $0.02Q4 2025-$0.07Miss by $0.04Q3 2025-$0.12Miss by $0.03Q2 2025-$0.18Beat by $0.01Q1 2025-$0.22In line
Q4 2024-$0.27Miss by $0.03

Ask the moment Rani Therapeutics Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Rani Therapeutics Holdings, Inc. report Q4 2024 earnings?
Rani Therapeutics Holdings, Inc. (RANI) reported Q4 2024 earnings on March 31, 2025 after market close.
What were Rani Therapeutics Holdings, Inc.'s Q4 2024 revenue and EPS?
Rani Therapeutics Holdings, Inc. reported revenue of $1.0M and eps of $-0.27 for Q4 2024.
Did Rani Therapeutics Holdings, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.24 by $0.03.
Where can I find Rani Therapeutics Holdings, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-047740) directly on SEC EDGAR. The filing index links above go to sec.gov.